Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/1513 stock hub

HKG/1513 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1513is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1513

In the news

Latest news · HKG/1513

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.7

P25 11.7P50 18.9P75 41.4

Trailing P/E13.4

P25 10.7P50 17.9P75 38.5

ROE15.1

P25 -14.7P50 2P75 9.4

ROIC26.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1513 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	8,878
Employees Change	134%
Employees Change Percent	1.5
Enterprise value	HKD 23.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001QV5
Last refreshed	2026-05-10
Market cap	HKD 30B
Price	HKD 27.72
Price currency	HKD
Rev Per Employee	1,499,348.39x
Sector	Healthcare
Sic	2834
Symbol	hkg/1513
Website	https://www.livzon.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.44%
EV Earnings	10.38x
EV/EBIT	7.85x
EV/EBITDA	6.43x
EV/FCF	7.51x
EV/Sales	1.72x
FCF yield	10.28%
Forward P/E	12.7x
P/B ratio	1.69x
P/E ratio	13.44x
P/S ratio	2.25x
PE Ratio10 Y	17.6x
PE Ratio3 Y	14.72x
PE Ratio5 Y	15.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.9%
EBITDA Margin	26.54%
FCF margin	23.17%
Gross margin	65.84%
Gross Profit	HKD 8.8B
Gross Profit Growth	2.36%
Gross Profit Growth Q	-8.47%
Gross Profit Growth3 Y	-0.82%
Gross Profit Growth5 Y	0.88%
Net Income	HKD 2.2B
Net Income Growth	-6.05%
Net Income Growth Q	-9.39%
Net Income Growth Years	0%
Net Income Growth3 Y	0.44%
Net Income Growth5 Y	1.36%
Pretax Margin	23.53%
Profit Margin	16.77%
Profit Per Employee	HKD 251,384
Profitable Years	34
ROA	6.59
Roa5y	5.74
ROCE	15.83
ROE	15.06
Roe5y	14.3
ROIC	26.68
Roic5y	24.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.84%
Cagr1y	10.25%
Cagr3y	3.82%
Cagr5y	0.59%
Div CAGR10	35.44%
Div CAGR3	-7.44%
Div CAGR5	-0.88%
EPS Growth	-3.95
EPS Growth Q	-8.45
EPS Growth Years	0
EPS Growth3 Y	2.11
EPS Growth5 Y	2.48
FCF Growth	21.91%
FCF Growth Q	24.26%
FCF Growth3 Y	22.47%
FCF Growth5 Y	12.47%
OCF Growth	16.5%
OCF Growth Q	12.8%
OCF Growth10 Y	12.58%
OCF Growth3 Y	11.08%
OCF Growth5 Y	6.96%
Revenue Growth	-0.34x
Revenue Growth Q	-9.74x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.32x
Revenue Growth5 Y	0.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.48
Assets	HKD 27.5B
Cash	HKD 11.3B
Current Assets	HKD 18B
Current Liabilities	HKD 9.2B
Debt	HKD 3.4B
Debt EBITDA	HKD 0.95
Debt Equity	HKD 0.19
Debt FCF	HKD 1.09
Equity	HKD 17.7B
Interest Coverage	49.34
Liabilities	HKD 9.8B
Long Term Assets	HKD 9.5B
Long Term Liabilities	HKD 588.6M
Net Cash	HKD 8B
Net Cash By Market Cap	HKD 26.53
Net Cash Growth	-0.57%
Net Debt EBITDA	HKD -2.25
Net Debt Equity	HKD -0.45
Net Debt FCF	HKD -2.58
Tangible Book Value	HKD 15.8B
Tangible Book Value Per Share	HKD 17.83
WACC	5.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	2.33
Net Working Capital	HKD 563.3M
Quick ratio	1.66
Working Capital	HKD 8.7B
Working Capital Turnover	HKD 1.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.19%
Dividend Growth	-19.11%
Dividend Growth Years	0%
Dividend per share	HKD 1.2
Dividend Years	12
Dividend Yield	4.33%
Ex Div Date	2025-06-13
Last Dividend	HKD 1.2
Payout Frequency	Annual
Payout Ratio	52.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	155.49%
1Y total return	10.24%
200-day SMA	31.84
3Y total return	11.91%
50-day SMA	28.17
50-day SMA vs 200-day SMA	50under200
5Y total return	3.01%
All Time High	42.6
All Time High Change	-34.93%
All Time High Date	2020-07-15
All Time Low	12.29
All Time Low Change	125.57%
All Time Low Date	2015-07-08
ATR	0.66
Beta	0.28
Ch YTD	-2.81
High	27.86
High52	41.85
High52 Date	2025-07-22
High52ch	-33.76%
Low	27.6
Low52	25.65
Low52 Date	2025-05-08
Low52ch	8.07%
Ma50ch	-1.61%
Price vs 200-day SMA	-12.94%
RSI	44.14
RSI Monthly	47.72
RSI Weekly	40.63
Sharpe ratio	0.36x
Sortino ratio	0.79
Total Return	6.52%
Tr YTD	-2.81
Tr1m	-5.07%
Tr1w	-0.22%
Tr3m	-5.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 2.9B
Operating Income Growth	-3.31
Operating Income Growth Q	-6.88
Operating Income Growth3 Y	10.04
Operating Income Growth5 Y	3.1
Operating margin	21.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	460,482,340%
Net Borrowing	-1,059,001,203.3
Shares Insiders	0.39%
Shares Institutions	13.74%
Shares Qo Q	0%
Shares Yo Y	-2.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 3.1B
Average Volume	909,134.8x
Bv Per Share	18.57
CAPEX	HKD -596.6M
Ch10y	66.63
Ch1m	-5.07
Ch1w	-0.22
Ch1y	6.21
Ch3m	-5.46
Ch3y	-4.74
Ch5y	-20.57
Ch6m	-13.54
Change	0.14%
Change From Open	-0.14
Close	27.68
Days Gap	0.29
Depreciation Amortization	625,978,884.6
Dollar Volume	15,905,736
Earnings Date	2026-04-23
EBIT	HKD 2.9B
EBITDA	HKD 3.5B
EPS	HKD 2.51
F Score	7
FCF	HKD 3.1B
FCF EV Yield	13.31x
Financing CF	-2,954,890,391
Fiscal Year End	December
Founded	1,985
Goodwill	143,843,240.1
Graham Number	27.56196
Graham Upside	-0.57
Income Tax	HKD 481.7M
Investing CF	-4,995,870,268
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2019-07-03
Last Split Type	Forward
Lynch Fair Value	HKD 10.31
Lynch Upside	-62.8
Ma150	30.05
Ma150ch	-7.76%
Ma20	28.38
Ma20ch	-2.31%
Net CF	-4,436,992,536
Next Earnings Date	2026-08-20
Open	27.76
P FCF Ratio	9.73
P OCF Ratio	8.15
Payment Date	2025-07-11
Position In Range	46.15
Ppne	4,915,814,485.7
Price Date	2026-05-08
Price EBITDA	HKD 8.49
Ptbv Ratio	1.9
Relative Volume	0.59x
Revenue	13,311,215,035x
Tax By Revenue	3.62x
Tax Rate	15.38%
Tr6m	-13.54%
Volume	573,800
Z Score	4.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1513 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.3%

$1.20 annual per share

Payout ratio

+52.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-0.9%

0 consecutive years of growth

Total shareholder yield

+6.5%

Next ex-dividend date: 2025-06-13

Performance

HKG/1513 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1513?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.7%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.2%

Negative means the company is buying back shares.

Technical

HKG/1513 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.1

Neutral momentum band

Price vs 200-day MA

-12.9%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1513

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1513 stock rating?

hkg/1513 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1513 analysis?

The full report lives at /stocks/hkg/1513/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1513?

The latest report frames hkg/1513 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1513 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.